414 related articles for article (PubMed ID: 18034431)
21. Identification of new pathogenic players in lupus: autoantibody-secreting cells are present in nephritic kidneys of (NZBxNZW)F1 mice.
Lacotte S; Dumortier H; Décossas M; Briand JP; Muller S
J Immunol; 2010 Apr; 184(7):3937-45. PubMed ID: 20181885
[TBL] [Abstract][Full Text] [Related]
22. Amelioration of SLE-like manifestations in (NZBxNZW)F1 mice following treatment with a peptide based on the complementarity determining region 1 of an autoantibody is associated with a down-regulation of apoptosis and of the pro-apoptotic factor JNK kinase.
Rapoport MJ; Sharabi A; Aharoni D; Bloch O; Zinger H; Dayan M; Mozes E
Clin Immunol; 2005 Dec; 117(3):262-70. PubMed ID: 16257268
[TBL] [Abstract][Full Text] [Related]
23. IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice.
Haas C; Ryffel B; Le Hir M
J Immunol; 1998 Apr; 160(8):3713-8. PubMed ID: 9558072
[TBL] [Abstract][Full Text] [Related]
24. Interferon-beta: a therapeutic for autoimmune lupus in MRL-Faslpr mice.
Schwarting A; Paul K; Tschirner S; Menke J; Hansen T; Brenner W; Kelley VR; Relle M; Galle PR
J Am Soc Nephrol; 2005 Nov; 16(11):3264-72. PubMed ID: 16221871
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus.
Pawar RD; Ramanjaneyulu A; Kulkarni OP; Lech M; Segerer S; Anders HJ
J Am Soc Nephrol; 2007 Jun; 18(6):1721-31. PubMed ID: 17460144
[TBL] [Abstract][Full Text] [Related]
26. DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo.
Lenert P; Yasuda K; Busconi L; Nelson P; Fleenor C; Ratnabalasuriar RS; Nagy PL; Ashman RF; Rifkin IR; Marshak-Rothstein A
Arthritis Res Ther; 2009; 11(3):R79. PubMed ID: 19476613
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus.
Lech M; Kantner C; Kulkarni OP; Ryu M; Vlasova E; Heesemann J; Anz D; Endres S; Kobayashi KS; Flavell RA; Martin J; Anders HJ
Ann Rheum Dis; 2011 Dec; 70(12):2207-17. PubMed ID: 21875872
[TBL] [Abstract][Full Text] [Related]
28. Immunology. Discriminating microbe from self suffers a double toll.
Goodnow CC
Science; 2006 Jun; 312(5780):1606-8. PubMed ID: 16778043
[No Abstract] [Full Text] [Related]
29. Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis.
Ozmen L; Roman D; Fountoulakis M; Schmid G; Ryffel B; Garotta G
Eur J Immunol; 1995 Jan; 25(1):6-12. PubMed ID: 7843255
[TBL] [Abstract][Full Text] [Related]
30. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.
Lövgren T; Eloranta ML; Båve U; Alm GV; Rönnblom L
Arthritis Rheum; 2004 Jun; 50(6):1861-72. PubMed ID: 15188363
[TBL] [Abstract][Full Text] [Related]
31. Prevention and reversal of lupus in NZB/NZW mice by costimulatory blockade with adeno-associated virus-mediated gene transfer.
Ye X; Zhu T; Bastacky S; McHale T; Li J; Xiao X
Arthritis Rheum; 2005 Dec; 52(12):3975-86. PubMed ID: 16329128
[TBL] [Abstract][Full Text] [Related]
32. Toll-like receptor activation in the pathogenesis of systemic lupus erythematosus.
Means TK; Luster AD
Ann N Y Acad Sci; 2005 Dec; 1062():242-51. PubMed ID: 16461805
[TBL] [Abstract][Full Text] [Related]
33. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
[TBL] [Abstract][Full Text] [Related]
34. Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9.
Guiducci C; Tripodo C; Gong M; Sangaletti S; Colombo MP; Coffman RL; Barrat FJ
J Exp Med; 2010 Dec; 207(13):2931-42. PubMed ID: 21115693
[TBL] [Abstract][Full Text] [Related]
35. Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function.
Kalled SL; Cutler AH; Datta SK; Thomas DW
J Immunol; 1998 Mar; 160(5):2158-65. PubMed ID: 9498753
[TBL] [Abstract][Full Text] [Related]
36. Suppression of glomerulonephritis in lupus-prone NZB × NZW mice by RN486, a selective inhibitor of Bruton's tyrosine kinase.
Mina-Osorio P; LaStant J; Keirstead N; Whittard T; Ayala J; Stefanova S; Garrido R; Dimaano N; Hilton H; Giron M; Lau KY; Hang J; Postelnek J; Kim Y; Min S; Patel A; Woods J; Ramanujam M; DeMartino J; Narula S; Xu D
Arthritis Rheum; 2013 Sep; 65(9):2380-91. PubMed ID: 23754328
[TBL] [Abstract][Full Text] [Related]
37. Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice.
Berland R; Fernandez L; Kari E; Han JH; Lomakin I; Akira S; Wortis HH; Kearney JF; Ucci AA; Imanishi-Kari T
Immunity; 2006 Sep; 25(3):429-40. PubMed ID: 16973388
[TBL] [Abstract][Full Text] [Related]
38. Immunization with peptides derived from the idiotypic region of lupus-associated autoantibodies delays the development of lupus nephritis in the (SWR x NZB)F1 murine model.
Stoll ML; Price KD; Silvin CJ; Jiang F; Gavalchin J
J Autoimmun; 2007 Aug; 29(1):30-7. PubMed ID: 17459659
[TBL] [Abstract][Full Text] [Related]
39. Systemic administration of interleukin-4 expressing plasmid DNA delays the development of glomerulonephritis and prolongs survival in lupus-prone female NZB x NZW F1 mice.
Hayashi T; Hasegawa K; Sasaki Y; Mori T; Adachi C; Maeda K
Nephrol Dial Transplant; 2007 Nov; 22(11):3131-8. PubMed ID: 17670770
[TBL] [Abstract][Full Text] [Related]
40. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation.
Chauhan SK; Singh VV; Rai R; Rai M; Rai G
J Clin Immunol; 2013 Jul; 33(5):954-64. PubMed ID: 23564191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
